Erector Spinae Plane Block in Spine Surgeries for Postoperative Pain
NCT ID: NCT06970704
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-12-31
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analgesic Efficacy of Different Volumes in Erector Spinae Plane Block in Single Level Lumbar Spine Fixation
NCT05892887
Erector Spinae Plane Block in Spine Surgeries
NCT05247021
Effectiveness of Bilateral Ultrasound-Guided Erector Spinae Plane Block
NCT04110210
Analgesic Efficacy of the Erector Spinae Plane Block Using Bupivacaine Versus Bupivacaine/Magnesium Sulphate in Patients Undergoing Lumbar Spine Surgery
NCT04433624
Thoracolumber Oterfacial Plane Block for Spine Surgery
NCT03060681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the Erector Spinae Plane block (ESPB) group, after prone positioning and before surgery, Erector Spinae Plane Block will be performed bilaterally using a low-frequency curved ultrasound transducer placed in a longitudinal orientation 3 cm lateral to the spinous process one vertebral level above a predetermined marked surgical incision. An 8-cm 22-gauge block needle will be inserted in a cephalad to caudad direction until the tip lies in the interfascial plane below the erector spinae muscle; the block will be performed by injection of 20 ml of 0.25% bupivacaine. In both groups, fentanyl 1 µg/kg as rescue analgesia will be given based on hemodynamic parameters.
If the mean arterial blood pressure (MAP) has fallen below 65 mmHg, 5 mg of ephedrine will be administered, and an intravenous bolus of 0.5 mg of atropine will be administered in case of bradycardia if the heart rate ≤50 bpm. The blood pressure will return to the baseline value before surgical field closure. Then at the end of surgery, the isoflurane vaporizer will be turned off, and the muscle relaxant will be reversed with neostigmine 0.04 mg/kg and atropine 0.02 mg/kg. The endotracheal tube will be removed after the patient regains consciousness and full muscle power, breathes spontaneously, and responds to verbal commands. Isoflurane consumption was measured at the end of surgery.
Postoperative pain management:
A standardized analgesic regimen will be prescribed in the postoperative period. All patients will receive 1 gm of paracetamol every 6 h. If the numeric rating scale (NRS) is more than 3, intravenous morphine 3mg will be administered by an investigator blinded to group assignment.
Clinical evaluation:
Total intravenous drug administration at the post-anesthesia care unit (PACU) and over the 48 hours was recorded. Opioid-related adverse events arising from the analgesic protocol will be systematically assessed at the PACU and surgical ward. The presence of nausea, vomiting, respiratory depression, pruritus, urinary retention requiring evacuation, allergy, and hallucinations will be recorded as binary (yes/no). Arterial oxygen saturation (pulse oximetry), heart and respiratory rates, and blood pressure will also be recorded every 6 hours.
The Ramsay Sedation Scale will be assessed postoperatively. The Ramsay sedation scale comprises two clearly defined groups of scores: those of 1, 2, and 3 are given in assessing degrees of wakefulness, and those of 4, 5, and 6 are given in assessing degrees of sleep. The six levels of the Ramsay sedation scale allow for visual assessments of sedation in patients who are responsive to such assessments
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Erector Spinae Plane Block (ESPB) (Study)
Patients in this group will receive Erector Spinae Plane Block (20 ml bupivacaine 0.25%) combined with general anesthesia
Erector Spinae Plane Block using 0.25 % bupivacaine
After induction of anesthesia and prone positioning and before surgery, Erector Spinae Plane Block was performed bilaterally using a low-frequency curved ultrasound transducer placed in a longitudinal orientation 3 cm lateral to the spinous process one vertebral level above a predetermined marked surgical incision. An 8-cm 22-gauge block needle was inserted in a cephalad to caudad direction until the tip lay in the interfascial plane below the erector spinae muscle, the block was performed by injection of 20 ml of 0.25% bupivacaine. Fentanyl 1 µg/kg as a rescue analgesia was given based on hemodynamic parameters.
Group General Anesthesia (GA) (Control)
Patients in this group will receive conventional general anesthesia
Erector Spinae Plane Block using 0.25 % bupivacaine
After induction of anesthesia and prone positioning and before surgery, Erector Spinae Plane Block was performed bilaterally using a low-frequency curved ultrasound transducer placed in a longitudinal orientation 3 cm lateral to the spinous process one vertebral level above a predetermined marked surgical incision. An 8-cm 22-gauge block needle was inserted in a cephalad to caudad direction until the tip lay in the interfascial plane below the erector spinae muscle, the block was performed by injection of 20 ml of 0.25% bupivacaine. Fentanyl 1 µg/kg as a rescue analgesia was given based on hemodynamic parameters.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector Spinae Plane Block using 0.25 % bupivacaine
After induction of anesthesia and prone positioning and before surgery, Erector Spinae Plane Block was performed bilaterally using a low-frequency curved ultrasound transducer placed in a longitudinal orientation 3 cm lateral to the spinous process one vertebral level above a predetermined marked surgical incision. An 8-cm 22-gauge block needle was inserted in a cephalad to caudad direction until the tip lay in the interfascial plane below the erector spinae muscle, the block was performed by injection of 20 ml of 0.25% bupivacaine. Fentanyl 1 µg/kg as a rescue analgesia was given based on hemodynamic parameters.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The American Society of Anesthesiology (ASA) physical status I-II
3. Scheduled for elective lumbar spine surgical procedures
Exclusion Criteria
2. BMI \> 30 or \< 18 kg/m2
3. Patients with surgical site infection
4. Known sensitivity or contraindication to local anesthetics
5. History of psychological disorders
6. Patients with unstable spine integrity like fractures or scoliosis
7. Hypertensive, cardiac, and diabetic patients,
8. Known alcohol or substance abuse within the last 6 months and Daily opioid intake
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University Hospitals
Cairo, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Prabhakar NK, Chadwick AL, Nwaneshiudu C, Aggarwal A, Salmasi V, Lii TR, Hah JM. Management of Postoperative Pain in Patients Following Spine Surgery: A Narrative Review. Int J Gen Med. 2022 May 2;15:4535-4549. doi: 10.2147/IJGM.S292698. eCollection 2022.
Ye Y, Bi Y, Ma J, Liu B. Thoracolumbar interfascial plane block for postoperative analgesia in spine surgery: A systematic review and meta-analysis. PLoS One. 2021 May 21;16(5):e0251980. doi: 10.1371/journal.pone.0251980. eCollection 2021.
Hyland SJ, Brockhaus KK, Vincent WR, Spence NZ, Lucki MM, Howkins MJ, Cleary RK. Perioperative Pain Management and Opioid Stewardship: A Practical Guide. Healthcare (Basel). 2021 Mar 16;9(3):333. doi: 10.3390/healthcare9030333.
Jin Y, Zhao S, Cai J, Blessing M, Zhao X, Tan H, Li J. Erector Spinae Plane Block for Perioperative Pain Control and Short-term Outcomes in Lumbar Laminoplasty: A Randomized Clinical Trial. J Pain Res. 2021 Sep 3;14:2717-2727. doi: 10.2147/JPR.S321514. eCollection 2021.
Rasheed AM, Amirah MF, Abdallah M, P J P, Issa M, Alharthy A. Ramsay Sedation Scale and Richmond Agitation Sedation Scale: A Cross-sectional Study. Dimens Crit Care Nurs. 2019 Mar/Apr;38(2):90-95. doi: 10.1097/DCC.0000000000000346.
Nashibi M, Sezari P, Safari F, Teymourian H, Asgari S, Mottaghi K. The effect of erector spinae plane block on the use of anesthetic medications in lumbar spine surgery. Agri. 2023 Oct;35(4):228-235. doi: 10.14744/agri.2022.48992.
Elewa AM, Faisal M, Sjoberg F, Abuelnaga ME. Comparison between erector spinae plane block and paravertebral block regarding postoperative analgesic consumption following breast surgery: a randomized controlled study. BMC Anesthesiol. 2022 Jun 18;22(1):189. doi: 10.1186/s12871-022-01724-3.
Zhang Q, Wu Y, Ren F, Zhang X, Feng Y. Bilateral ultrasound-guided erector spinae plane block in patients undergoing lumbar spinal fusion: A randomized controlled trial. J Clin Anesth. 2021 Feb;68:110090. doi: 10.1016/j.jclinane.2020.110090. Epub 2020 Oct 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU MS 681/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.